Stage-specific antimalarial activity of cysteine protease inhibitors

被引:24
|
作者
Shenai, BR [1 ]
Semenov, AV [1 ]
Rosenthal, PJ [1 ]
机构
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94143 USA
基金
美国国家卫生研究院;
关键词
chemotherapy; malaria; Plasmodium; protease; proteinase;
D O I
10.1515/BC.2002.089
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cysteine proteases of the malaria parasite Plasmodium falciparum, known as falcipains, are promising targets for antimalarial chemotherapy. We evaluated cultured parasites for the stagespecific expression of cysteine proteases and sensitivity to cysteine protease inhibitors. Protease activity and inhibitor sensitivity varied markedly over time. Cysteine protease activity was greatest in early trophozoites, while sensitivity to cysteine protease inhibitors was greatest in mature trophozoites. Our results indicate the importance of considering the stagespecific effects of antimalarials and are consistent with the conclusion that the principal antimalarial activity of cysteine protease inhibitors is due to a block in hemoglobin hydrolysis.
引用
收藏
页码:843 / 847
页数:5
相关论文
共 50 条
  • [21] Stage-specific activity of potential antimalarial compounds measured in vitro by flow cytometry in comparison to optical microscopy and hypoxanthine uptake
    Contreras, CE
    Rivas, MA
    Domínguez, J
    Charris, J
    Palacios, M
    Bianco, NE
    Blanca, I
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2004, 99 (02): : 179 - 184
  • [22] Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors
    Parikh, S
    Gut, J
    Istvan, E
    Goldberg, DE
    Havlir, DV
    Rosenthal, PJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) : 2983 - 2985
  • [23] Antimalarial activity of sera from subjects taking HIV protease inhibitors
    Redmond, Andrew M.
    Skinner-Adams, Tina
    Andrews, Katherine T.
    Gardiner, Donald L.
    Ray, John
    Kelly, Mark
    McCarthy, James S.
    AIDS, 2007, 21 (06) : 763 - 765
  • [24] Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis
    Huthmacher, Carola
    Hoppe, Andreas
    Bulik, Sascha
    Holzhutter, Hermann-Georg
    BMC SYSTEMS BIOLOGY, 2010, 4
  • [25] Synthesis and antimalarial activity of novel hydroxyethylamines, potential aspartyl protease inhibitors
    Cunico, Wilson
    G. Ferreira, Maria de Lourdes
    Ferreira, Thais G.
    Penido, Carmen
    M. O. Henriques, Maria G.
    Krettli, Luisa G.
    Varotti, Fernando P.
    Krettli, Antoniana U.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2008, 5 (03) : 178 - 181
  • [26] Borrelidin, a potent antimalarial: stage-specific inhibition profile of synchronized cultures of Plasmodium falciparum
    Aki Ishiyama
    Masato Iwatsuki
    Miyuki Namatame
    Aki Nishihara-Tsukashima
    Toshiaki Sunazuka
    Yoko Takahashi
    Satoshi Ōmura
    Kazuhiko Otoguro
    The Journal of Antibiotics, 2011, 64 : 381 - 384
  • [27] Borrelidin, a potent antimalarial: stage-specific inhibition profile of synchronized cultures of Plasmodium falciparum
    Ishiyama, Aki
    Iwatsuki, Masato
    Namatame, Miyuki
    Nishihara-Tsukashima, Aki
    Sunazuka, Toshiaki
    Takahashi, Yoko
    Omura, Satoshi
    Otoguro, Kazuhiko
    JOURNAL OF ANTIBIOTICS, 2011, 64 (05): : 381 - 384
  • [28] Stage-specific regulation of caspase activity in Drosophila oogenesis
    Peterson, JS
    Barkett, M
    McCall, K
    DEVELOPMENTAL BIOLOGY, 2003, 260 (01) : 113 - 123
  • [29] Cysteine protease inhibitors in angiogenesis
    Bell, A
    Baer, RW
    Cox, JL
    FASEB JOURNAL, 2005, 19 (04): : A837 - A837
  • [30] Proteinaceous cysteine protease inhibitors
    Dubin, G
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2005, 62 (06) : 653 - 669